HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

485.171

+2.8150.58%

Number of Gainers:21

Number of Losers:10

Number of Flat:2

PE:- -

High:489.931

Open:482.072

Low:481.405

Close:482.357

Volume:61.61M

Turnover:1.28B

Market Cap:307.98B

Float Cap:273.83B

Loading ...

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation

Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market

Jinan Pingjia's 60% Stake Relisted at 24 Million Yuan After Once Being Valued at 154 Million

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

ALPHAMAB-B Repurchases 115,000 Shares for HK$989,200 on September 7

Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.6 Each

SinoMab BioScience Held Shareholder Meeting, Disposal Resolution Drew 100% Support

Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future

Riding on One-Off Licensing Income, Suzhou Zelgen's Hong Kong Listing Ambitions Face Scrutiny Amid First Post-IPO Semi-Annual Profit

Ascletis Pharma Joins Two Chinese Stock Connect Programs

MT Newswires Live

HBM Holdings Enters Shanghai-, Shenzhen-Hong Kong Stock Connects

MT Newswires Live

CStone Pharmaceuticals Joins Stock Connect Southbound Trading

MT Newswires Live

Kintor Pharma Shares Rise as Skin Tone Treatment Inches Closer to Approval After Trial Results

MT Newswires Live

Medical Device Inspection Campaign Launched by Ningyang County Market Regulators

MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential

Ascletis Announces Inclusion in the Hong Kong Stock Connect List Under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs

THOMSON REUTERS

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Hong Kong Stock Market Flash | METIS TECHBIO-P (07666) Surges Over 15% in Morning Session, Leading the AI Drug Development Sector as AI4S Commercialization Picks Up Pace

ALEBUND-B Announced H Shares Inclusion in Stock Connect and Hang Seng Composite Index

HBM Holdings-B(02142) Shares Added to Shanghai and Shenzhen-Hong Kong Stock Connect Lists

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK1574/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":485.17123,"timestamp":1789632487194,"preClose":482.35672,"halted":0,"volume":61610930,"delay":0,"changeRate":0.005835,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":2.814514,"latestTime":"09-17 16:00:00","open":482.07187,"high":489.93134,"low":481.40475,"amount":1281540013.5,"amplitude":0.017677,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789695000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":3.604829,"peRate":160.310337,"turnoverRate":0.002293,"increases":18,"decrements":10,"flats":4,"marketCap":307980316848,"floatMarketCap":273827471128},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":489.93134,"amplitude":0.017677,"preClose":482.35672,"low":481.40475,"pbRate":"3.604829","latestPrice":485.17123,"volume":61610930,"delay":0,"open":482.07187,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":496.758,"twentyDayClose":517.015,"sixtyDayClose":440.071,"secType":"PLATE","market":"HK","turnoverRate":0.002293,"peRate":160.310337,"marketCap":307980316848,"floatMarketCap":273827471128,"timestamp":1789632487194,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":21,"down":10,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665311564","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311564","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311564?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:12","pubTimestamp":1788783177,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return on share buyback cancellationZylox-Tonbridge repurchased 53,500 H shares on Sept. 7, 2026 for holding as treasury shares; no shares were cancelled","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL100F5h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02190","BK1583","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106718626","title":"Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1106718626","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106718626?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:51","pubTimestamp":1788781895,"startTime":"0","endTime":"0","summary":"Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488) has disclosed its intention to participate in a collective earnings presentation tailored for the innovative drug sector on the STAR Market,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","KSTR","159992","BK0262","688488","IBBQ","LNGR","BK1574","MEDX","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135498525","title":"Jinan Pingjia's 60% Stake Relisted at 24 Million Yuan After Once Being Valued at 154 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1135498525","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135498525?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:21","pubTimestamp":1788780087,"startTime":"0","endTime":"0","summary":"More than two years have passed since the failed acquisition, and the 60% equity stake in Jinan Pingjia is once again on the property rights trading market, now with a minimum listing price of 24...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1515","301017","BK0209","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143231072","title":"Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1143231072","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143231072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:20","pubTimestamp":1788780027,"startTime":"0","endTime":"0","summary":"Remegen Co., Ltd. announced on September 7 that it will join the collective earnings communication session for the innovative drug industry on the STAR Market for the first half of 2026, scheduled...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KSTR","LU1969619763.USD","LU1064131003.USD","BK1161","LU2328871848.SGD","06978","BK0239","BK1583","IBBQ","159992","MEDX","BK1574","LU1064130708.USD","LU2488822045.USD","LNGR","09995","LU2148510915.USD","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179966506","title":"ALPHAMAB-B Repurchases 115,000 Shares for HK$989,200 on September 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1179966506","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179966506?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:20","pubTimestamp":1788776414,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) announced that on September 7, 2026, it spent HK$989,200 to repurchase 115,000 shares.The buyback reflects the company's ongoing capital management strategy, with the repurchased...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315451","title":"Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.6 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315451","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315451?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:16","pubTimestamp":1788776202,"startTime":"0","endTime":"0","summary":"Alphamab Oncology files HKEX next-day return disclosing share repurchase at HKD 8.6 eachAlphamab Oncology repurchased 115,000 ordinary shares on Sept. 7, holding all as treasury shares.Buyback price r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL4b0tJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09966","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665200318","title":"SinoMab BioScience Held Shareholder Meeting, Disposal Resolution Drew 100% Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2665200318","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665200318?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:07","pubTimestamp":1788772023,"startTime":"0","endTime":"0","summary":"SinoMab BioScience held shareholder meeting, disposal resolution drew 100% supportSinoMab BioScience held an extraordinary general meeting on Sept. 7, 2026.Shareholders adopted a resolution to confirm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL9Tlkd2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182662414","title":"Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future","url":"https://stock-news.laohu8.com/highlight/detail?id=1182662414","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182662414?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:21","pubTimestamp":1788769307,"startTime":"0","endTime":"0","summary":"Shares of Zhejiang Anglikang Pharmaceutical Co.,Ltd. (002940.SZ) briefly hit the daily limit up on September 4th, buoyed by news of medical insurance negotiations and the launch of commercial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002940","BK1161","IBBQ","159992","LNGR","BK0239","BK1574","06978","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142074973","title":"Riding on One-Off Licensing Income, Suzhou Zelgen's Hong Kong Listing Ambitions Face Scrutiny Amid First Post-IPO Semi-Annual Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1142074973","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142074973?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:28","pubTimestamp":1788766134,"startTime":"0","endTime":"0","summary":"Suzhou Zelgen Biopharmaceuticals Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange main board, marking its second attempt, with China International Capital Corporation...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEXmain","BK0239","IPOS","01477","BK1574","688266","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665474394","title":"Ascletis Pharma Joins Two Chinese Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665474394","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665474394?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:34","pubTimestamp":1788762852,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said it has been included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective Sept. 7.The inclusion allows mainland Chinese investors to trade the biotech company's Hong Kong-listed shares through the Stock Connect platform, according to a Monday Hong Kong bourse filing.Shares of the drugmaker rose over 2% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02823","BK1515","XPP","02843","82823","KBA","ASHS","YINN","ASHR","82822","YXI","KCAI","KWEB","CWEB","82843","BK1574","01672","BK1161","02822","YANG","CHAU","FXP","FLCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665941093","title":"HBM Holdings Enters Shanghai-, Shenzhen-Hong Kong Stock Connects","url":"https://stock-news.laohu8.com/highlight/detail?id=2665941093","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665941093?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:29","pubTimestamp":1788762578,"startTime":"0","endTime":"0","summary":"HBM Holdings'  shares have been included as eligible stocks under the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, according to a Monday bourse filing with the Hong Kong bourse.Qualified investors in mainland China can now directly invest in the company's shares through these Stock Connect programs.Shares of the biopharmaceutical company fell 1% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK4588","KWEB","HBMX","FLCH","MIC","02142","ASHS","MUU","YINN","MUZ","RAMZ","YANG","XPP","DRAL","YXI","KCAI","02823","DISK","DRMP","MUYY","02843","CWEB","DRMY","BK1161","BK1574","CHAU","02822","ASHR","RAM","DRAM","MULL","82822","82843","MUG","KBA","MUD","82823","FXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665943143","title":"CStone Pharmaceuticals Joins Stock Connect Southbound Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2665943143","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665943143?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:11","pubTimestamp":1788761498,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (HKG:2616) said its Hong Kong-listed shares have been added to the eligible securities list for southbound trading under Stock Connect, effective Sept. 7, according to a same-day Hong Kong bourse filing.Shares of the biopharmaceutical company fell nearly 1% in recent trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KWEB","YXI","02843","YINN","FLCH","FXP","82843","02616","XPP","82822","CWEB","02822","ASHR","02823","BK1161","BK1574","KBA","YANG","ASHS","KCAI","82823","CHAU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665992903","title":"Kintor Pharma Shares Rise as Skin Tone Treatment Inches Closer to Approval After Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665992903","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665992903?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:11","pubTimestamp":1788757872,"startTime":"0","endTime":"0","summary":"Kintor Pharmaceutical  has disclosed positive results from the long-term safety trial of its skin tone correcting treatment, KT-939, according to a Monday bourse filing.Preliminary data showed that KT-939 was safe and well-tolerated, and participants treated with it for about a year did not experience any adverse skin reactions, the company said.Kintor said it is now working to advance KT-939's registration application for approval by the National Medical Products Administration before launching it commercially.The company's shares are up 5.5% in midday trading on the HKEX.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09939","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155170383","title":"Medical Device Inspection Campaign Launched by Ningyang County Market Regulators","url":"https://stock-news.laohu8.com/highlight/detail?id=1155170383","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155170383?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:41","pubTimestamp":1788756073,"startTime":"0","endTime":"0","summary":"On September 7, enforcement officers from the Market Supervision Administration of Ningyang County, Shandong Province, visited retail pharmacies within their jurisdiction to conduct a targeted...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","BK1100","BK1583","PTH","09996","159883","LGHT","HART","IEIH","LNGR","MDEV","MEDX","GDOC","AGNG","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191894169","title":"MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1191894169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191894169?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:18","pubTimestamp":1788754720,"startTime":"0","endTime":"0","summary":"As a wave of interim earnings reports floods in from medical device companies, the sector's recovery trajectory has become increasingly clear, with a definitive upward inflection point now visible in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","BK1583","BK4585","MEDX","BK1100","VXUS","LNGR","AGNG","HART","RSPH","PTH","BK4588","IEIH","BK1574","02041","LGHT","MDEV","KCAI","GDOC","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399806","title":"Ascletis Announces Inclusion in the Hong Kong Stock Connect List Under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399806?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:15","pubTimestamp":1788754501,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUABQ4B5D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1161","BK1574","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109390642","title":"UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1109390642","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109390642?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:50","pubTimestamp":1788745830,"startTime":"0","endTime":"0","summary":"UBS has released a research note suggesting that while market expectations for the Chinese biotech sector's first-half results were initially conservative—due to concerns over tighter domestic drug...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0463099449.HKD","LU2399975544.HKD","HK0000165453.HKD","LU1188198961.HKD","06160","09969","LU0417516738.SGD","LU0348783233.USD","LU1794554557.SGD","LU2097828557.USD","BK1587","BK1500","LU0348766576.USD","LU2476274720.SGD","LU0307460666.USD","LU1303224171.USD","LU0502904849.HKD","LU0634319403.HKD","LU0828237510.HKD","LU1961090484.USD","LU0196878994.USD","BK1589","LU2328871848.SGD","09926","BK4585","BK1515","LU0348784397.USD","KURE","ONC","LU2488822045.USD","LU0348767384.USD","688235","BK4588","IE00B5MMRT66.SGD","LU0348735423.USD","LU0417516571.SGD","LU2097828805.USD","LU2242644610.SGD","BK1588","BK4139","IE00B543WZ88.USD","LU0588546209.SGD","BK1161","03069","BK1191","BK4526","BK1583","LU0348825331.USD","LU0540923850.HKD","LU1770034418.SGD","LU0561508036.HKD","LU0326950275.SGD","LU2097828474.EUR","LU1251922891.USD","00013","LU1720050803.USD","06990","01801","LU1719994722.HKD","IE00BPRC5H50.USD","LU2476274308.USD","LU0417516902.SGD","LU0228659784.USD","LU0455707207.USD","BK0239","BK1574","LU0348827113.USD","LU1969619763.USD","LU2097828631.EUR","01877","LU2778985437.USD","LU0244354667.USD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125017479","title":"Hong Kong Stock Market Flash | METIS TECHBIO-P (07666) Surges Over 15% in Morning Session, Leading the AI Drug Development Sector as AI4S Commercialization Picks Up Pace","url":"https://stock-news.laohu8.com/highlight/detail?id=1125017479","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125017479?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:48","pubTimestamp":1788745710,"startTime":"0","endTime":"0","summary":"Shares of METIS TECHBIO-P (07666) climbed more than 15% in the morning trading session, taking the lead among AI drug development concept stocks. As of the time of writing, the stock was up 12.81%,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","07666","BK1574","VXUS","QTOC","CHAT","BK1161","BK4585","KCAI","01477","VTHR","BK4588","AGIX","AIPO","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187807186","title":"ALEBUND-B Announced H Shares Inclusion in Stock Connect and Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=1187807186","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187807186?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:00","pubTimestamp":1788742832,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) has announced that, in accordance with the relevant arrangements and adjustments for Stock Connect, its H shares have been included in the list of eligible securities for Stock...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","HSCI","FLHK","09939","09637","159938","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135620236","title":"HBM Holdings-B(02142) Shares Added to Shanghai and Shenzhen-Hong Kong Stock Connect Lists","url":"https://stock-news.laohu8.com/highlight/detail?id=1135620236","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135620236?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:20","pubTimestamp":1788740410,"startTime":"0","endTime":"0","summary":"HBM Holdings-B (02142) announced that, effective September 7, 2026, its shares have been added to the lists of eligible securities under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","BK1161","02142"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":10,"totalSize":226,"code":"91000000","status":"200"}]}}